Urs Brändli
Chief Tech/Sci/R&D Officer bei DOTTIKON ES HOLDING AG
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Urs Brändli
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 01.01.2003 | - |
| Corporate Officer/Principal | 01.01.1990 | 01.01.2003 | |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - | - |
| Dottikon Es Management AG | Corporate Officer/Principal | - | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - | - |
Karriereverlauf von Urs Brändli
Statistik
International
| Schweiz | 4 |
| 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
| Dottikon ES Holding AG | |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es Management AG |
- Börse
- Insiders
- Urs Brändli
- Erfahrung
